KCAS Bio
KCAS Bio is a leading contract research organization (CRO) employing top scientific talent which provides comprehensive bioanalytical services to the global biopharmaceutical industry from early discovery support through product registration and beyond. KCAS Bio offers bioanalytical, biomarker, immunogenicity, cellular and molecular assay services along with clinical kitting and sample management. KCAS Bio operates in state-of-the-art facilities in the United States and Europe, with the expertise, capacity, and flexibility to support the development of all types of drugs, biologics, cell and gene therapies to improve health worldwide.
KCAS Bioanalytical and Biomarker Services appoints John Bucksath as new CEO
A Spotlight on immunogenicity: an interview with Joyce Slusser
Immunogenicity assay development
Emerging immuno-oncology therapies
Panel Discussion: Hot Topics in Large Molecule Bioanalysis
Franklin Spriggs: validating bioanalytical methods for biomarkers
Immunogenicity services and capabilities at KCAS Bioanalytical & Biomarker Services
Development & Validation of a Direct Method for Quantification of DNA in Digested Tissue Samples
John Bucksath (KCAS Bioanalytical & Biomarker Services) on ‘one stop shop’ laboratory services
Panel discussion: new technology integration in bioanalytical workflows
John Bucksath (KCAS Bioanalytical & Biomarker Services) on ‘one stop shop’ laboratory services
Panel discussion: the sharing of scientific data
Why flow cytometry at KCAS? Solving the mysteries of flow cytometry
Panel discussion: novel techniques and the new age of biomarkers
Panel discussion: gender parity in bioanalysis
Panel discussion: ICH M10 draft bioanalytical method validation guideline
Panel discussion: the evolution of flow cytometry
Panel discussion: strategies and challenges of immunogenicity
Panel discussion: what does the future hold for biomarker R&D?
Strategy for the selection and validation of your biomarkers for support of drug development
KCAS Bio specializes in the following services:
Bioanalysis
- Pharmacokinetics/ Toxicokinetics:
- LC-MS/MS, Hybrid LC-MS/MS, LBA, qPCR, ddPCR
- LNPs:
- LC-MS/MS, Hybrid LC-MS/MS
- Receptor occupancy:
- Flow cytometry
- Immunogenicity/ADA:
- LBA
- Biodistribution:
- qPCR, ddPCR
- Neutralizing antibodies assays:
- Cell-based, plate based
- Dose formulation analysis
- SEC, UPLC
Pharmacodynamics
- Primary endpoints
- Functional assays
- Secondary endpoints/ exploratory assays
Biomarkers
- Soluble biomarkers:
- LBA, qPCR, ddPCR, LC-MS/MS, MSD
- Cellular biomarkers:
- ELISpot, flow cytometry, qPCR, ddPCR, single-cell proteomics
Support
- Formulation analysis
- Sample kits (clinical/non clinical)
- Bio-repository
Learn more at www.kcasbio.com or follow us on twitter @KCASBio
Website:
www.kcasbio.com
Email:
[email protected]
Telephone:
913-248-3000
Address:
10830 S Clay Blair Blvd
Olathe, Kansas
66061
USA